CIK 0001372514 · Non-accelerated filer<br>Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980443284
- Phone
- 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −250 | $1.98 | $495 | 68,292 |
| 2021-11-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −62 | $1.98 | $123 | 15,136 |
| 2021-11-02 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −83 | $1.98 | $164 | 23,059 |
| 2021-10-21 | Strem Brian M. President and CEO | Grant or award | +9,517 | 9,517 | ||
| 2021-10-21 | Daniels Eric Joseph Chief Development Officer | Grant or award | +9,520 | 9,520 | ||
| 2021-10-21 | Daniels Eric Joseph Chief Development Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-10-04 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −83 | $2.01 | $167 | 23,142 |
| 2021-10-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −62 | $2.01 | $125 | 15,198 |
| 2021-10-04 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −249 | $2.01 | $500 | 68,542 |
| 2021-09-02 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −253 | $1.81 | $458 | 68,791 |
| 2021-09-02 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −84 | $1.81 | $152 | 23,225 |
| 2021-09-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −61 | $1.81 | $110 | 15,260 |
| 2021-08-03 | FROM STEPHEN Executive Chairman | Shares withheld for taxes | −261 | $2.40 | $626 | 69,044 |
| 2021-08-03 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −65 | $2.40 | $156 | 15,378 |
| 2021-08-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −63 | $2.40 | $151 | 15,321 |
| 2021-08-03 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −87 | $2.40 | $209 | 23,309 |
| 2021-08-02 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −192,775 | $2.40 | $463K | 785,000 |
| 2021-07-30 | ARMISTICE CAPITAL, LLC 10% owner | Sale | −68,188 | $2.69 | $184K | 977,775 |
| 2021-07-29 | ARMISTICE CAPITAL, LLC Director | Sale | −400,000 | $3.00 | $1.2M | 1,045,963 |
| 2021-07-28 | ARMISTICE CAPITAL, LLC Director | Sale | −375,443 | $3.28 | $1.2M | 1,445,963 |
Page 6 of 7 · 130 trades